Advertisement

Topics

Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

16:35 EDT 18th October 2017 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 200,000+

Wednesday 18th October 2017

Researchers Discover How UV Rays Cause Skin Cancer

ArticleUnder normal conditions, UV radiation from the sun activates melanocytes to release melanin.Staff Author: 

Toyota recalls some Sienna minivans for shifter defect

Toyota Motor Co. is recalling 347,120 Sienna minivans worldwide because they can shift out of the "park" position and roll away.

BRIEF—AbbVie in I-O deal with Californian biotech

US drugmaker AbbVie has announced an immuno-oncology (I-O) research collaboration with Harpoon Therapeutics,…

Genomic Vision: Report of the LSR R&D Day

A large panel of key opinion leaders presented the competitiveness of molecular combing in the fields of DNA replication and gene editing The Company reiterated the presentation of research conduc...

Researchers “Drug the Undruggable” Through Unique Collaboration

A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia created by Cancer Research UK.

Scientists Zero In on a New Target for Obesity

A compound that helps rodents and monkeys slim down could offer a promising approach for human therapies -- Read more on ScientificAmerican.com

'Undruggable' cancer protein successfully targeted with new drug combination

A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia created by Cancer Research UK.  The results of the study, published in Nature, show that two...

Gemini Therapeutics closes $42.5M Series A for dry age-related macular degeneration therapy

Atlas Venture, Lightstone Ventures and OrbiMed co-led the Series A for the therapeutics business, which is focused on genetic causes for the condition.

Medigene: Das gilt es für Anleger zu beachten!

Liebe Leser, Medigene musste zum Wochenauftakt eine kleine Korrektur im laufenden Aufwärtstrend hinnehmen. Die Aktie hatte binnen Wochenfrist ein Plus von annähernd 6 % geschafft. Damit näherte sic...

Anthem Joins With CVS to Start Its Own Pharmacy Business

The move is another shake-up in the pharmacy benefits manager industry, and deals a blow to Express Scripts.

Flexible ‘Skin’ Could Enhance Abilities of Robots, Prosthetics to Perform Everyday Tasks

NewsThe research team can measure these differences in electrical resistance.Contributed Author: 

BSN Spitout-AUT: Valneva fällt nach einem halben Jahr unter den MA200

Gestoppte bzw. gedrehte Serien: Zumtobel +0,37% auf 15,06, davor 6 Tage im Minus (-7,38% Verlust von 16,2 auf 15,01), Telekom Austria +0,11% auf 7,869, davor 4 Tage im Minus (-2,72% Verlust von 8,0...

Biotech Report: Santhera und Mologen klettern, Biogen nur noch leicht im Plus

shareribs.com - Biotech-Aktien zeigen sich im deutlichen Handel überwiegend fester, angeführt von Santhera und Mologen. An der Wall Street liegt der Sektor derweil unter Druck Den vollständigen Art...

BRIEF—CEO of regenerative medicine company resigns

Antony Odell is resigning from his role as chief executive of UK-based regenerative medicine company…

Hardy Coral Make Their Moves to Build New Reefs from Scratch

NewsThe findings suggest many existing coral habitats may have been created by coralliths.Contributed Author: 

Study Finds Water-Repelling Surfaces Ease Ice Removal

NewsTo compare the two forms of ice growth, the researchers designed a transparent surface split into halves.Contributed Author: 

Nano-Fiber Sutures Promote Production of Infection-Thwarting Peptide

NewsThe discovery could represent an important advance in the prevention of surgical site infections.

Vir announces multi-billion dollar agreements to boost R&D pipeline

San Franciscan firm Vir Biotechnology has announced a series of strategic deals aimed at boosting its…

US bid to repeal 2016 law seen as preventing aggressive DEA enforcement of opioid distributors

US President Donald Trump on Tuesday said his nominee to head the Office of National Drug Control Policy,…

Biogen-Aktie ist mehr wert! - Aktienanalyse

Charlotte - Biogen-Aktienanalyse des Analysten Ying Huang von BofA Merrill Lynch Research: Im Rahmen einer aktuellen Aktienanalyse spricht Ying Huang, Aktienanalyst von BofA Merrill Lynch Research ...

Cerenis Therapeutics: Completion of Patient Enrollment in the Phase 3 Study, TANGO, Evaluating CER-001 in HDL Genetic Deficiency

Regulatory News: Cerenis Therapeutics (FR0012616852 CEREN PEA PME eligible) (Paris:CEREN) an international biopharmaceutical company dedicated to the discovery and development of innovative therap...

World Hunger Is Increasing, Thanks to Wars and Climate Change

Despite efforts to end food shortages, a recent U.N. report shows that, after years of decline, hunger is on the rise again -- Read more on ScientificAmerican.com

WHO prequalification for Synflorix pneumococcal vaccine four-dose vial

The World Health Organization (WHO) has awarded prequalification for the new four-dose vial presentation…

Lilly and Germany's CureVac agree I-O deal worth up to $2 billion

Indianapolis, USA-based Eli Lilly and privately-held German firm CureVac have announced a global immuno-oncology…

Trump slams new bipartisan health care deal: What's in it?

Following negotiations that lasted for more than a month, Sen. Lamar Alexander (R-Tenn.) and Sen. Patty Murray (D-Wash.) have reached a deal to stabilize the insurance markets, just two weeks before the ObamaCare open enrollment period is set to begin.


Quick Search
Advertisement